DAY ONE
8.00-10.00 Registration, Coffee and networking
10.00-12.00 Key note speakers:
Professor Sir Christopher Evans, OBE
Chairman of the Life Science Sector Panel
Unveils the New and Vibrant Life Science
Strategy for Wales, and answers your questions
Professor Sir Richard Sykes
Former Chairman of GlaxoSmithKline
Opening address, sharing his experience and insights
Edwina Hart MBE OStJ AM
Minister for Business, Enterprise, Technology and Science
Professor John Harries
Chief Scientific Advisor for Wales
Science for Wales: A Strategic Agenda
Professor Trevor Jones
Former Director General
ABPI, Strategic direction of the Pharmaceutical Industry and the role of the SME business community
12.00-2.00 Lunch and networking
Professor Chris McGuigan
Cardiff University
ProTides: From Lab Science to Wall Street
Gabriele Cerronne
Chairman BioVitas Capital
From Cardiff and two employees to $2.5 Billion
Dr David Bott
Director of Innovation Programmes
Technology Strategy Board
Concept to Commercialisation in Life Sciences
John Jeans
Chairman, Cardiff University Council, Medical Research Council – Technology, and Imanova Ltd
Ian James
Director A4P Consulting
Innovation in Clinical Bioanalysis
Dr Nick Thomas
Principal Scientist in Cell Technologies, GE Healthcare
Rowan Gardner
Biolauncher
New Models for BioScience Innovation
6.00- 10.00pm
Drinks Reception
Medilink UK Awards Ceremony
Gala Dinner
|
|
DAY TWO
8.00 – 9.30 Coffee and networking
9.30 -12.00 Translation:
Michael Hunt
CEO Renuron
Developing Stem Cells therapy in stroke patients – the Translational Challenge
Berwyn Clarke
Board Director and Cheif Scientific Officer, Lab 21
Companion Diagnostics
David Ford and Dr Steven Conlan
Institute of Life Science
‘What’s the Point of Care?’ – Showing Research Makes a Difference
Professor Jonathan Bisson
Clinical Director, NISCHR AHSC
Collaborative working between industry, higher education and NHS Wales.
Trevor Howe
Janssen, a Johnson and Johnson Company
Lions and Donkeys – Will Translation improve Attrition in Parmaceutical research?
12.00- 2.00 Lunch and networking
2.00-4.30 Commercialisation:
Michael Thompson
Managing Director, Biomet UK Healthcare
Rapid Recovery Knee Arthroplasty Patient Pathway – A New Service Model for Orthopaedic Care
Kenneth Powell
Executive Chairman, Q Chip
Turning Good Science into Commercial Success –Case Histories from Biotechnology
Dr Pete Corish
British Biocell International (BBI)
Innovation Versus Process – the Balancing Act for Successful New Product Development in Diagnostics
Facilitated Finance Panel Discussions
- Ifan Evans Head of Life Science Sector, Welsh Governement
- Domonic Griffiths, Fusion IP
- Brenig Preest, Senior Investment Executive, Excalibur
- Dr Melanie Goward, Senior Inv
estment Executive, Finance Wales
Workshops
Day 1: UKTI – How to Access the US Healthcare Market
Day 2: GE Startup Workshop – Working with SMEs to deliver Growth
|